Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative evaluation of four exome enrichment solutions in 2024: Agilent, Roche, Vazyme and Nanodigmbio

27 Jan 2025

Abstract excerpt

Whole exome sequencing (WES) is essential for identifying genetic variants linked to diseases. This study compares available to date four exome enrichment kits: Agilent SureSelect Human All Exon v8, Roche KAPA HyperExome, Vazyme VAHTS Target Capture Core Exome Panel, and Nanodigmbio NEXome Plus Panel v1. We evaluated target design, coverage statistics, and variant calling accuracy across these four different...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Molecular Biology Techniques and Applications
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39871131
DOI: 10.1186/s12864-024-11196-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparative evaluation of four exome enrichment solutions in 2024: Agilent, Roche, Vazyme and NanodigmbioPMID 39871131Read ↗

Comparative evaluation of four exome enrichment solutions in 2024: Agilent, Roche, Vazyme and NanodigmbioSemantic proximity Read ↗

Performance comparison of four commercial human whole-exome capture platforms.Semantic proximity Read ↗

Comparison of Mendeliome exome capture kits for use in clinical diagnostics.Semantic proximity Read ↗

A systematic comparison of two new releases of exome sequencing products: the aim of use determines the choice of product.Semantic proximity Read ↗

Comprehensive comparison of three commercial human whole-exome capture platforms.Semantic proximity Read ↗

New insights into the performance of human whole-exome capture platforms.Semantic proximity Read ↗

Comparison of solution-based exome capture methods for next generation sequencing.Semantic proximity Read ↗

Performance comparison of four exome capture systems for deep sequencing.Semantic proximity Read ↗

Performance Comparison Of Agilent New SureSelect All Exon v8 Probes With v7 Probes For Exome SequencingSemantic proximity Read ↗

ECNano: A Cost-Effective Workflow for Target Enrichment Sequencing and Accurate Variant Calling on 4,800 Clinically Significant Genes Using a Single MinION FlowcellSemantic proximity Read ↗

Clinical exome sequencing in daily practice: 1,000 patients and beyondSemantic proximity Read ↗

Sanger sequencing is no longer always necessary based on a single-center validation of 1109 NGS variants in 825 clinical exomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.